194 related articles for article (PubMed ID: 15046922)
41. Polyhemoglobin with different percentage of tetrameric hemoglobin and effects on vasoactivity and electrocardiogram.
Yu B; Liu Z; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(2):159-73. PubMed ID: 16537172
[TBL] [Abstract][Full Text] [Related]
42. Liposome-encapsulated hemoglobin (hemoglobin-vesicle) is not transferred from mother to fetus at the late stage of pregnancy in the rat model.
Kaga M; Li H; Ohta H; Taguchi K; Ogaki S; Izumi H; Inagaki M; Tsuchiya S; Okamura K; Otagiri M; Sakai H; Yaegashi N
Life Sci; 2012 Oct; 91(11-12):420-428. PubMed ID: 22935405
[TBL] [Abstract][Full Text] [Related]
43. Prolonged oxygen-carrying ability of hemoglobin vesicles by coencapsulation of catalase in vivo.
Teramura Y; Kanazawa H; Sakai H; Takeoka S; Tsuchida E
Bioconjug Chem; 2003; 14(6):1171-6. PubMed ID: 14624631
[TBL] [Abstract][Full Text] [Related]
44. Static structures and dynamics of hemoglobin vesicle (HBV) developed as a transfusion alternative.
Sato T; Sakai H; Sou K; Medebach M; Glatter O; Tsuchida E
J Phys Chem B; 2009 Jun; 113(24):8418-28. PubMed ID: 19469497
[TBL] [Abstract][Full Text] [Related]
45. Liposome-Encapsulated Hemoglobin, TRM-645: Current Status of the Development and Important Issues for Clinical Application.
Kaneda S; Ishizuka T; Goto H; Kimura T; Inaba K; Kasukawa H
Artif Organs; 2009 Feb; 33(2):146-52. PubMed ID: 19178459
[TBL] [Abstract][Full Text] [Related]
46. Methemoglobin formation in hemoglobin vesicles and reduction by encapsulated thiols.
Takeoka S; Sakai H; Kose T; Mano Y; Seino Y; Nishide H; Tsuchida E
Bioconjug Chem; 1997; 8(4):539-44. PubMed ID: 9258453
[TBL] [Abstract][Full Text] [Related]
47. Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension.
Sakai H; Hara H; Yuasa M; Tsai AG; Takeoka S; Tsuchida E; Intaglietta M
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H908-15. PubMed ID: 10993749
[TBL] [Abstract][Full Text] [Related]
48. Swine hemoglobin as a potential source of artificial oxygen carriers, hemoglobin-vesicles.
Sakai H; Ng K; Li B; Sugimura N
Artif Cells Nanomed Biotechnol; 2013 Feb; 41(1):37-41. PubMed ID: 22992176
[TBL] [Abstract][Full Text] [Related]
49. Mechanism of flocculate formation of highly concentrated phospholipid vesicles suspended in a series of water-soluble biopolymers.
Sakai H; Sato A; Takeoka S; Tsuchida E
Biomacromolecules; 2009 Aug; 10(8):2344-50. PubMed ID: 19572642
[TBL] [Abstract][Full Text] [Related]
50. Measuring circulating blood volume using infused hemoglobin-based oxygen carrier (oxyglobin) as an indicator: verification in a canine hypovolemia model.
Jahr JS; Lurie F; Bezdikian V; Driessen B; Gunther RA
Am J Ther; 2008; 15(2):98-101. PubMed ID: 18356627
[TBL] [Abstract][Full Text] [Related]
51. Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats.
Wang XY; Ishida T; Ichihara M; Kiwada H
J Control Release; 2005 May; 104(1):91-102. PubMed ID: 15866337
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells.
Taguchi K; Maruyama T; Otagiri M
Drug Metab Rev; 2011 Aug; 43(3):362-73. PubMed ID: 21428698
[TBL] [Abstract][Full Text] [Related]
53. Removal of cellular-type hemoglobin-based oxygen carrier (hemoglobin-vesicles) from blood using centrifugation and ultrafiltration.
Sakai H; Sou K; Horinouchi H; Tsuchida E; Kobayashi K
Artif Organs; 2012 Feb; 36(2):202-9. PubMed ID: 21834949
[TBL] [Abstract][Full Text] [Related]
54. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
55. Safety Evaluation of Hemoglobin-Albumin Cluster "HemoAct" as a Red Blood Cell Substitute.
Haruki R; Kimura T; Iwasaki H; Yamada K; Kamiyama I; Kohno M; Taguchi K; Nagao S; Maruyama T; Otagiri M; Komatsu T
Sci Rep; 2015 Jul; 5():12778. PubMed ID: 26220366
[TBL] [Abstract][Full Text] [Related]
56. Biological Responsiveness and Metabolic Performance of Liposome-Encapsulated Hemoglobin (Hemoglobin-Vesicles) in Apolipoprotein E-Deficient Mice after Massive Intravenous Injection.
Taguchi K; Nagao S; Yamasaki K; Sakai H; Seo H; Maruyama T; Otagiri M
Biol Pharm Bull; 2015; 38(10):1606-16. PubMed ID: 26424021
[TBL] [Abstract][Full Text] [Related]
57. Characteristics of polylipid/Hb vesicles (ARC) (in vitro and in vivo test).
Nakachi O; Tokuyama S; Satoh T; Tsuchida E
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):635-40. PubMed ID: 1391487
[TBL] [Abstract][Full Text] [Related]
58. Alteration in the pharmacokinetics of hemoglobin-vesicles in a rat model of chronic liver cirrhosis is associated with Kupffer cell phagocyte activity.
Taguchi K; Miyasato M; Watanabe H; Sakai H; Tsuchida E; Horinouchi H; Kobayashi K; Maruyama T; Otagiri M
J Pharm Sci; 2011 Feb; 100(2):775-83. PubMed ID: 20799362
[TBL] [Abstract][Full Text] [Related]
59. Physiological responses, organ distribution, and circulation kinetics in anesthetized rats after hypovolemic exchange transfusion with technetium-99m-labeled liposome-encapsulated hemoglobin.
Goins B; Klipper R; Sanders J; Cliff RO; Rudolph AS; Phillips WT
Shock; 1995 Aug; 4(2):121-30. PubMed ID: 7496897
[TBL] [Abstract][Full Text] [Related]
60. A transient inflammatory reaction in the lung after experimental hemorrhagic shock and resuscitation with a hemoglobin-vesicles solution compared with rat RBC transfusion.
Yamanashi Y; Mori M; Terajima K; Tsueshita T; Horinouchi H; Sakai H; Sakamoto A
ASAIO J; 2009; 55(5):478-83. PubMed ID: 19625952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
